-
Science Saturday: Brain organoids and neuropsychiatric disorders
Share this:
Mayo Clinic and Yale University collaborated in a study published in Science to create a new model for studying neuropsychiatric disorders in early human brain development. This unique collaboration brought together Mayo Clinic’s team-based, patient-centered research with Yale researchers to discover and analyze the genetic mechanisms that may cause these disorders.
The Mayo Clinic team, led by biomedical scientist Alexej Abyzov, Ph.D., used the organoid model to analyze artificially grown cells that resemble the brain (brain organoids) to outline groups of developmental genes and regulatory elements related to the cause of autism.
Researchers know that genes implicated in neuropsychiatric disorders are active in the human fetal brain. However, systematic and comprehensive studies are hampered due to the difficulty in getting fetal brain tissue. According to Dr. Abyzov, the power of organoids is that they can be created from the skin cells of any individual. Read the rest of the article on the Individualized Medicine blog.
_________________________
Other Mayo Clinic medical research websites:
- Research at Mayo Clinic
- Discovery’s Edge
- Advancing the Science
- Forefront
- Mayo Clinic Center for Individualized Medicine
- Center for Regenerative Medicine
- Center for the Science of Health Care Delivery
Share this:
Related articles
ROCHESTER, Minn., and REDMOND, Wash. — Mayo Clinic, a world leader in healthcare known for its commitment to innovation, is among the first healthcare organizations ...
Nearly 3 million Americans are living with a heart condition called atrial fibrillation, according to the American Heart Association. And the Centers for Disease Control ...
September is Thyroid Cancer Awareness Month, which makes this a good time to learn about treating thyroid cancer. Nearly 44,000 new cases of thyroid cancer will be diagnosed ...